148 related articles for article (PubMed ID: 3224036)
1. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistological analysis of infiltrating lymphocyte subpopulations in gliomas and metastatic brain tumors].
Saito T; Tanaka R; Kouno M; Takai N; Yoshida S; Hara N; Washiyama K; Sekiguchi K; Kumanishi T
No To Shinkei; 1987 Apr; 39(4):339-45. PubMed ID: 2439110
[TBL] [Abstract][Full Text] [Related]
3. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
Matsuhisa T
No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
[TBL] [Abstract][Full Text] [Related]
4. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].
Numa Y; Kawamoto K; Matsumura H
No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857
[TBL] [Abstract][Full Text] [Related]
5. [Separation and functional analysis of tumor-infiltrating lymphocytes in brain tumor tissues].
Saito T; Tanaka R; Takai N; Hara N; Yoshida S
No To Shinkei; 1988 Dec; 40(12):1137-42. PubMed ID: 3266842
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
Hosokawa T
Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
[TBL] [Abstract][Full Text] [Related]
7. [A new treatment of malignant brain tumor -1: local injection of bleomycin (author's transl)].
Nakazawa S; Ohwaki K; Shimura T; Itoh Y; Yajima K
No Shinkei Geka; 1981 Dec; 9(13):1487-93. PubMed ID: 6179006
[TBL] [Abstract][Full Text] [Related]
8. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
[TBL] [Abstract][Full Text] [Related]
9. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].
Fujioka T; Shiraishi M; Tanji S; Koike H; Suzuki K; Kumagai K; Aoki H; Sakuma Y; Ohhori T; Kubo T
Hinyokika Kiyo; 1989 Feb; 35(2):253-7. PubMed ID: 2735236
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].
Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Maeshiro H; Shigematsu H; Matsumi N; Matsumoto K; Furuta T; Nishimoto A
No To Shinkei; 1989 Dec; 41(12):1195-201. PubMed ID: 2697376
[TBL] [Abstract][Full Text] [Related]
11. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
Bodey B; Bodey B; Siegel SE
Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
[TBL] [Abstract][Full Text] [Related]
13. Immunopathology of metastases in patients of colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factor.
Shetye J; Ragnhammar P; Liljefors M; Christensson B; Frödin JE; Biberfeld P; Mellstedt H
Clin Cancer Res; 1998 Aug; 4(8):1921-9. PubMed ID: 9717820
[TBL] [Abstract][Full Text] [Related]
14. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
Belldegrun A; Muul LM; Rosenberg SA
Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
[TBL] [Abstract][Full Text] [Related]
17. [Local immunotherapy for cancer].
Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
[TBL] [Abstract][Full Text] [Related]
18. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
19. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor effect of direct intra-tumor administration of OK-432 on malignant glioma: basic and clinical observations].
Fujisawa K; Kanno T; Yokoi K; Onouchi K; Kawase T; Abe M
No Shinkei Geka; 1991 Mar; 19(3):241-6. PubMed ID: 2038413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]